Canadian Securities Exchange (CSE) · BNXT.CN · ISIN CA0909741062
BioNxt Solutions Inc.
0.4050 CAD
+0.02(+3.85%)upPrevious close · Sep 17, 17:20 ET
Data last updated: (2 d ago)· Delayed exchange data
BioNxt Solutions Inc. (BNXT.CN) trades on the Canadian Securities Exchange and operates in the Drug Manufacturers - Specialty & Generic industry. Its market capitalisation is approximately 44.2M CAD. The company reports around 25 employees. Its ISIN is CA0909741062. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Checking today's session…
Key facts
Exchange
Canadian Securities Exchange (CSE)
ISIN
CA0909741062
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Market cap
52.65M CAD
Employees
25
Previous close
0.39 CAD
Day range
0.41 – 0.41
52-week range
0.28 – 0.91
Volume
44.44K
50-day average
0.33 CAD
200-day average
0.47 CAD
Asset type
Equity
About BioNxt Solutions Inc.
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
Company websiteFrequently asked
- What is the BNXT.CN share price today?
- This page shows the latest available BioNxt Solutions Inc. (BNXT.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is BioNxt Solutions Inc. listed?
- BioNxt Solutions Inc. trades on the Canadian Securities Exchange under the symbol BNXT.CN, ISIN CA0909741062.
- How large is BioNxt Solutions Inc.?
- Its market capitalisation is approximately 44.2M CAD, based on the latest available price and share count from our data provider.
+
+
+
All BioNxt Solutions Inc. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.